(Q40565562)

21 September 2017

title

Oncolysis of hepatic metastasis of colorectal cancer by recombinant vesicular stomatitis virus in immune-competent mice (English)

1 reference

21 September 2017

1 reference

1 reference

4

1 reference

21 September 2017

1

Tian-Gui Huang

1 reference

21 September 2017

Oliver Ebert

2

1 reference

21 September 2017

Katsunori Shinozaki

series ordinal

3

1 reference

21 September 2017

Savio L C Woo

series ordinal

5

1 reference

21 September 2017

publication date

1 September 2003

1 reference

21 September 2017

1 reference

21 September 2017

volume

8

1 reference

21 September 2017

issue

3

1 reference

21 September 2017

page(s)

434-440

1 reference

21 September 2017

cites work

Cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900204-1

7 January 2021

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900204-1

7 January 2021

Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900204-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900204-1

1 reference

7 January 2021

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900204-1

7 January 2021

Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900204-1

7 January 2021

The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900204-1

7 January 2021

PKR; a sentinel kinase for cellular stress

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900204-1

7 January 2021

Oncogenes in Ras signalling pathway dictate host-cell permissiveness to herpes simplex virus 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900204-1

7 January 2021

Reovirus therapy of tumors with activated Ras pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900204-1

7 January 2021

Recombinant vesicular stomatitis viruses from DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900204-1

7 January 2021

Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900204-1

7 January 2021

Replication-competent rhabdoviruses with human immunodeficiency virus type 1 coats and green fluorescent protein: entry by a pH-independent pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900204-1

7 January 2021

Combination gene therapy for liver metastasis of colon carcinoma in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900204-1

7 January 2021

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900204-1

7 January 2021

Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900204-1

7 January 2021

Hepatoma-specific antitumor activity of an albumin enhancer/promoter regulated herpes simplex virus in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900204-1

7 January 2021

Replication, establishment of latency, and induced reactivation of herpes simplex virus gamma 1 34.5 deletion mutants in rodent models

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900204-1

7 January 2021

Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900204-1

7 January 2021

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900204-1

7 January 2021

ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900204-1

7 January 2021

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900204-1

7 January 2021

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900204-1

7 January 2021

Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900204-1

7 January 2021

Replicative adenoviruses for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900204-1

7 January 2021

Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900204-1

7 January 2021

Rejection of disseminated metastases of colon carcinoma by synergism of IL-12 gene therapy and 4-1BB costimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900204-1

7 January 2021

Immunomodulatory gene therapy with interleukin 12 and 4-1BB ligand: long- term remission of liver metastases in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900204-1

7 January 2021

OX40 ligation enhances primary and memory cytotoxic T lymphocyte responses in an immunotherapy for hepatic colon metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900204-1

7 January 2021

Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or myc function and involves the induction of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900204-1

7 January 2021

Genetically engineered vesicular stomatitis virus in gene therapy: application for treatment of malignant disease

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900204-1

7 January 2021

10.1016/S1525-0016(03)00204-1

Identifiers

DOI

1 reference

21 September 2017

1 reference